Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Zhongchao Inc. Announces 1-for-10 Share Consolidation 2024-02-27 21:00
New Models of PENTAX Medical i20c Video Endoscope Series Obtain CE Marks 2024-02-27 17:00
Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China 2024-02-27 16:09
Amaris B. Clinic's Research Reveals Dynamic Skin Care Priorities Across Age Groups in Singapore 2024-02-27 15:21
Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E. 2024-02-27 12:40
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
Sengenics Corporation Announces Key Distributor in China 2024-02-27 08:30
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis 2024-02-27 07:14
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics 2024-02-27 05:55
Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases 2024-02-27 01:06
BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062 2024-02-26 22:38
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. 2024-02-26 21:30
OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED - HIGHLIGHTING NATIONAL GENDER PAIN GAP 2024-02-26 21:01
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization 2024-02-26 21:00
Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") launches MOTPOLY XR™ (lacosamide) extended-release capsules C-V, the first, and only once-daily formulation of lacosamide 2024-02-26 21:00
TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor 2024-02-26 21:00
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024) 2024-02-26 16:15
Encouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-02-26 14:37
Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care 2024-02-26 10:10
Siriraj Hospital Expands Services to Provide Advanced Medical Care, Highlights State-of-the-Art Technology for Cancer Treatment 2024-02-26 08:00
1 91 92 93 94 95 1564